Global Neutron Capture Therapy of Cancer Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Neutron Capture Therapy of Cancer Market Research Report 2024
Neutron capture therapy (NCT) is a type of radiotherapy for treating locally invasive malignant tumors such as primary brain tumors, recurrent cancers of the head and neck region, and cutaneous and extracutaneous melanomas. It is a two-step processfirst, the patient is injected with a tumor-localizing drug containing the stable isotope boron-10 (10B), which has a high propensity to capture low energy "thermal" neutrons. The neutron cross section of 10B (3,837 barns) is 1,000 times more than that of other elements, such as nitrogen, hydrogen, or oxygen, that occur in tissue. In the second step, the patient is radiated with epithermal neutrons, the sources of which in the past have been nuclear reactors and now are accelerators that produce higher energy epithermal neutrons.
According to MRAResearch’s new survey, global Neutron Capture Therapy of Cancer market is projected to reach US$ 248 million in 2033, increasing from US$ 84 million in 2022, with the CAGR of 13.5% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Neutron Capture Therapy of Cancer market research.
Key companies engaged in the Neutron Capture Therapy of Cancer industry include TAE Life Sciences, RaySearch, Neutron Therapeutics, International Particle Therapy, Southern TOHOKU Hospital Group and Neuboron Medtech, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Neutron Capture Therapy of Cancer were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Neutron Capture Therapy of Cancer market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Neutron Capture Therapy of Cancer market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
TAE Life Sciences
RaySearch
Neutron Therapeutics
International Particle Therapy
Southern TOHOKU Hospital Group
Neuboron Medtech
Segment by Type
Thermal Beam
Epithermal Beam
Brain Tumor
Extracranial Tumor
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Neutron Capture Therapy of Cancer report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Neutron Capture Therapy of Cancer market is projected to reach US$ 248 million in 2033, increasing from US$ 84 million in 2022, with the CAGR of 13.5% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Neutron Capture Therapy of Cancer market research.
Key companies engaged in the Neutron Capture Therapy of Cancer industry include TAE Life Sciences, RaySearch, Neutron Therapeutics, International Particle Therapy, Southern TOHOKU Hospital Group and Neuboron Medtech, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Neutron Capture Therapy of Cancer were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Neutron Capture Therapy of Cancer market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Neutron Capture Therapy of Cancer market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
TAE Life Sciences
RaySearch
Neutron Therapeutics
International Particle Therapy
Southern TOHOKU Hospital Group
Neuboron Medtech
Segment by Type
Thermal Beam
Epithermal Beam
Segment by Application
Brain Tumor
Extracranial Tumor
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Neutron Capture Therapy of Cancer report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source